AMD vs. JNJ: Advanced Micro Devices vs. Johnson & Johnson Stock Comparison
How do Advanced Micro Devices (AMD) and Johnson & Johnson (JNJ) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.
Company Profile
Advanced Micro Devices (AMD) is classified in the Information Technology sector (Semiconductors & Semiconductor Equipment), whereas Johnson & Johnson (JNJ) belongs to Health Care (Pharmaceuticals, Biotechnology & Life Sciences) — their GICS classifications point to very different parts of the market.
| Profile Item | AMD | JNJ |
|---|---|---|
| Name | Advanced Micro Devices Inc. | Johnson & Johnson |
| Country/Region | United States | United States |
| GICS Sector | Information Technology | Health Care |
| GICS Industry Group | Semiconductors & Semiconductor Equipment | Pharmaceuticals, Biotechnology & Life Sciences |
| GICS Industry | Semiconductors & Semiconductor Equipment | Pharmaceuticals |
| GICS Sub-Industry | Semiconductors | Pharmaceuticals |
| Market Capitalization | 736.46 billion USD | 664.95 billion USD |
| Currency | USD | USD |
| Exchange | Nasdaq | NYSE |
| Listing Date | March 17, 1980 | January 2, 1962 |
| Security Type | Common Stock | Common Stock |
Price Performance
Cumulative Growth
Trailing Returns
Calendar-Year Returns
Performance Metrics
| Metric | AMD | JNJ |
|---|---|---|
| Total Return (1Y) | 114.18% | 53.82% |
| Total Return (3Y, Annualized) | 63.95% | 27.51% |
| Total Return (5Y, Annualized) | 27.42% | 14.71% |
Risk Profile
Drawdown History
Return Distribution
Risk Metrics
Advanced Micro Devices (AMD) has a highly aggressive beta of 2.53, indicating much higher sensitivity to broad-market moves, while Johnson & Johnson (JNJ) is defensive at 0.21 and tends to be less market-sensitive — a wide gap in beta profiles.
| Metric | AMD | JNJ |
|---|---|---|
| Volatility (1Y, Annualized) | 72.86% | 21.23% |
| Beta (5Y) | 2.53 | 0.21 |
| Max Drawdown (5Y) | -65.45% | -18.41% |
| Avg. Volume (3M) | 22.40M | 6.93M |
Risk-Adjusted Performance
Risk-Return Positioning
Risk-Adjusted Metrics
| Metric | AMD | JNJ |
|---|---|---|
| Sharpe Ratio (1Y) | 1.51 | 2.33 |
| Sortino Ratio (1Y) | 2.32 | 3.66 |
Profitability
ROE (TTM)
Johnson & Johnson (JNJ) at 20.02% sits in the top ROE quartile, while Advanced Micro Devices (AMD) at 11.96% is closer to the peer norm — stronger capital efficiency for JNJ.
AMD
Semiconductors & Semiconductor Equipment industry group
11.96%
- Max
- 52.82%
- Q3
- 22.26%
- AMD
- 11.96%
- Median
- 10.58%
- Q1
- 1.29%
- Min
- -16.89%
JNJ
Pharmaceuticals, Biotechnology & Life Sciences industry group
20.02%
- Max
- 109.18%
- JNJ
- 20.02%
- Q3
- 6.23%
- Median
- -26.66%
- Q1
- -64.05%
- Min
- -167.77%
Net Margin (TTM)
Johnson & Johnson (JNJ) at 16.20% retains a top-quartile share of revenue as profit, ahead of Advanced Micro Devices (AMD) at 16.77%, which keeps about the industry-typical share.
AMD
Semiconductors & Semiconductor Equipment industry group
16.77%
- Max
- 63.80%
- Q3
- 28.36%
- AMD
- 16.77%
- Median
- 11.44%
- Q1
- 0.90%
- Min
- -37.77%
JNJ
Pharmaceuticals, Biotechnology & Life Sciences industry group
16.20%
- Max
- 18.05%
- JNJ
- 16.20%
- Q3
- 4.78%
- Median
- 0.00%
- Q1
- -4.14%
- Min
- -17.05%
Operating Margin (TTM)
Johnson & Johnson (JNJ) at 25.74% operates in the top operating margin quartile, ahead of Advanced Micro Devices (AMD) at 21.17%, which runs around its industry’s norm.
AMD
Semiconductors & Semiconductor Equipment industry group
21.17%
- Max
- 58.66%
- Q3
- 30.23%
- AMD
- 21.17%
- Median
- 15.91%
- Q1
- 7.54%
- Min
- -25.74%
JNJ
Pharmaceuticals, Biotechnology & Life Sciences industry group
25.74%
- Max
- 83.12%
- JNJ
- 25.74%
- Q3
- 14.77%
- Median
- 0.00%
- Q1
- -78.82%
- Min
- -207.40%
Profitability Metrics
| Metric | AMD | JNJ |
|---|---|---|
| ROE (TTM) | 11.96% | 20.02% |
| ROA (TTM) | 5.90% | 8.46% |
| Net Margin (TTM) | 16.77% | 16.20% |
| Operating Margin (TTM) | 21.17% | 25.74% |
| Gross Margin (TTM) | 56.00% | 67.78% |
Growth
Revenue Growth
Advanced Micro Devices (AMD) at 34.34% sits in the top revenue growth quartile, while Johnson & Johnson (JNJ) at 6.05% is closer to the peer norm — faster top-line expansion for AMD.
EPS Growth
Both companies show strong earnings momentum, but Advanced Micro Devices (AMD) at 165.00% is the standout with EPS growth above its industry range; Johnson & Johnson (JNJ) at 90.50% also sits in the top quartile.
Growth Metrics
| Metric | AMD | JNJ |
|---|---|---|
| Revenue Growth (YoY) | 34.34% | 6.05% |
| Revenue Growth (3Y CAGR) | 13.64% | 5.60% |
| EPS Growth (YoY) | 165.00% | 90.50% |
| EPS Growth (3Y CAGR) | 46.66% | 17.90% |
Financial Strength
Current Ratio (MRQ)
Advanced Micro Devices (AMD) at 2.73 keeps current ratio within its industry’s typical mid-range, while Johnson & Johnson (JNJ) at 1.02 runs in the tighter-liquidity quartile — a thinner cushion against current liabilities for JNJ.
AMD
Semiconductors & Semiconductor Equipment industry group
2.73
- Max
- 10.33
- Q3
- 5.62
- Median
- 3.33
- AMD
- 2.73
- Q1
- 2.35
- Min
- 1.03
JNJ
Pharmaceuticals, Biotechnology & Life Sciences industry group
1.02
- Max
- 25.13
- Q3
- 12.13
- Median
- 5.52
- Q1
- 2.47
- JNJ
- 1.02
- Min
- 0.10
Debt / Equity (MRQ)
Both Advanced Micro Devices (AMD) at 0.13 and Johnson & Johnson (JNJ) at 0.55 fund their balance sheets with roughly industry-typical debt-to-equity mixes.
AMD
Semiconductors & Semiconductor Equipment industry group
0.13
- Max
- 1.46
- Q3
- 0.65
- Median
- 0.27
- AMD
- 0.13
- Q1
- 0.04
- Min
- 0.00
JNJ
Pharmaceuticals, Biotechnology & Life Sciences industry group
0.55
- Max
- 1.42
- Q3
- 0.65
- JNJ
- 0.55
- Median
- 0.15
- Q1
- 0.02
- Min
- 0.00
Financial Strength Metrics
| Metric | AMD | JNJ |
|---|---|---|
| Current Ratio (MRQ) | 2.73 | 1.02 |
| Debt / Equity (MRQ) | 0.13 | 0.55 |
| Net Debt / EBITDA | -0.59 | 0.79 |
Dividends
Dividend Yield (TTM)
Advanced Micro Devices (AMD) pays no dividend (yield 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile Johnson & Johnson (JNJ) reports a yield of 1.94%, ranking against industry peers normally.
AMD
Semiconductors & Semiconductor Equipment industry group
0.00%
- Max
- 1.37%
- Q3
- 0.65%
- AMD
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
JNJ
Pharmaceuticals, Biotechnology & Life Sciences industry group
1.94%
- JNJ
- 1.94%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Payout Ratio (TTM)
Advanced Micro Devices (AMD) pays no dividend (payout 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile Johnson & Johnson (JNJ) reports a payout of 80.12%, ranking against industry peers normally.
AMD
Semiconductors & Semiconductor Equipment industry group
0.00%
- Max
- 49.64%
- Q3
- 21.71%
- AMD
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
JNJ
Pharmaceuticals, Biotechnology & Life Sciences industry group
80.12%
- JNJ
- 80.12%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Metrics
| Metric | AMD | JNJ |
|---|---|---|
| Dividend Yield (TTM) | 0.00% | 1.94% |
| Dividend Payout Ratio (TTM) | 0.00% | 80.12% |
Valuation
P/E Ratio (TTM)
Johnson & Johnson (JNJ) at 41.92 is near its industry’s usual P/E ratio, while Advanced Micro Devices (AMD) at 95.95 sits in the richer quartile — AMD needs stronger growth or earnings quality to justify the premium.
AMD
Semiconductors & Semiconductor Equipment industry group
95.95
- Max
- 110.34
- AMD
- 95.95
- Q3
- 66.81
- Median
- 37.02
- Q1
- 23.96
- Min
- 8.12
JNJ
Pharmaceuticals, Biotechnology & Life Sciences industry group
41.92
- Max
- 85.34
- Q3
- 43.46
- JNJ
- 41.92
- Median
- 26.69
- Q1
- 13.30
- Min
- 0.07
P/S Ratio (TTM)
Johnson & Johnson (JNJ) at 6.69 is priced about in line with its industry on P/S ratio, while Advanced Micro Devices (AMD) at 16.21 sits in the pricier quartile — AMD costs more per dollar of sales.
AMD
Semiconductors & Semiconductor Equipment industry group
16.21
- Max
- 21.42
- AMD
- 16.21
- Q3
- 12.27
- Median
- 5.76
- Q1
- 2.73
- Min
- 0.00
JNJ
Pharmaceuticals, Biotechnology & Life Sciences industry group
6.69
- Max
- 58.18
- Q3
- 25.77
- Median
- 7.30
- JNJ
- 6.69
- Q1
- 3.01
- Min
- 0.01
P/B Ratio (MRQ)
Both Advanced Micro Devices (AMD) at 10.77 and Johnson & Johnson (JNJ) at 8.16 carry a premium to book value versus peers, sitting in the upper P/B ratio quartile of their industries.
AMD
Semiconductors & Semiconductor Equipment industry group
10.77
- Max
- 14.06
- AMD
- 10.77
- Q3
- 7.44
- Median
- 4.29
- Q1
- 2.30
- Min
- 0.20
JNJ
Pharmaceuticals, Biotechnology & Life Sciences industry group
8.16
- Max
- 13.53
- JNJ
- 8.16
- Q3
- 6.54
- Median
- 3.25
- Q1
- 1.69
- Min
- -5.59
Valuation Metrics
| Metric | AMD | JNJ |
|---|---|---|
| P/E Ratio (TTM) | 95.95 | 41.92 |
| P/S Ratio (TTM) | 16.21 | 6.69 |
| P/B Ratio (MRQ) | 10.77 | 8.16 |
| Free Cash Flow Yield (TTM) | 1.00% | 2.78% |